Research ArticleCancer

Antagonism of EGFR and Notch limits resistance to EGFR inhibitors and radiation by decreasing tumor-initiating cell frequency

See allHide authors and affiliations

Science Translational Medicine  08 Mar 2017:
Vol. 9, Issue 380, eaag0339
DOI: 10.1126/scitranslmed.aag0339

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine

Navigate This Article